Skip to search.
 All Ordinaries Up 0.64%
Streaming
Ticker Tape: On

More On PGL.AX

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

Ownership

Financials

Progen Pharmaceuticals Ltd (PGL.AX)

-ASX
0.90 Down 0.05(5.26%) 23 Apr 16:10
Add to Portfolio
Prev Close:0.95
Open:0.89
Bid:0.87
Ask:1.00
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.87 - 0.90
52wk Range:0.15 - 1.29
Volume:21,000
Avg Vol (3m):38,954
Market Cap:49.76M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Headlines

  • No Headlines available for PGL.AX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progen Pharmaceuticals Limited, a biotechnology company, discovers, researches, and develops biopharmaceutical therapeutics for the treatment of human diseases in Australia and the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback